Insider Transactions in Q2 2024 at Catalyst Pharmaceuticals, Inc. (CPRX)
Insider Transaction List (Q2 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 07
2024
|
Jeffrey Del Carmen Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
7,541
-29.04%
|
$120,656
$16.07 P/Share
|
|
Jun 05
2024
|
Gary Ingenito Chief Med. & Reg. Officer |
SELL
Open market or private sale
|
Direct |
80,000
-60.89%
|
$1,280,000
$16.16 P/Share
|
|
Jun 05
2024
|
Gary Ingenito Chief Med. & Reg. Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
80,000
+37.84%
|
$320,000
$4.01 P/Share
|
|
Jun 04
2024
|
Richard J Daly President and CEO |
SELL
Open market or private sale
|
Direct |
17,323
-6.87%
|
$259,845
$15.97 P/Share
|
|
Jun 04
2024
|
Richard J Daly President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
40,000
+13.69%
|
$160,000
$4.01 P/Share
|
|
Jun 03
2024
|
Molly Harper Director |
SELL
Open market or private sale
|
Direct |
5,333
-100.0%
|
$85,328
$16.3 P/Share
|
|
Apr 08
2024
|
David S Tierney Director |
SELL
Open market or private sale
|
Direct |
25,000
-6.69%
|
$375,000
$15.68 P/Share
|
|
Apr 08
2024
|
David S Tierney Director |
BUY
Exercise of conversion of derivative security
|
Direct |
25,000
+6.27%
|
$100,000
$4.01 P/Share
|